The present invention relates to methods for reducing testosterone levels byreduction of luteinizing hormone (LH)or independent of LH levels in a male subject and methods of treating,suppressing, reducing the incidence, reducing the severity,or inhibiting advanced prostate cancer and palliative treatment of advancedprostate cancer.